Charming Medical Limited (MCTA)

Charming Medical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023
Cash & Equivalents	2.69	2.1	1.93
Short-Term Investments	0.07	0.89	1.82
Cash & Cash Equivalents	2.77	2.99	3.75
Cash Growth	-	-20.22%	-
Receivables	0.39	0.35	0.19
Inventory	0.03	0.03	0.07
Other Current Assets	0.12	0.3	0.12
Total Current Assets	3.31	3.67	4.12
Property, Plant & Equipment	-	0.47	0.65
Goodwill and Intangibles	-	0.45	1.15
Other Long-Term Assets	-	0.29	0.47
Total Long-Term Assets	-	1.21	2.26
Total Assets	-	4.88	6.38
Accounts Payable	-	0.45	0.24
Deferred Revenue	-	4.5	5.6
Current Debt	-	0.81	1.33
Other Current Liabilities	5.6	0.12	0
Total Current Liabilities	5.6	5.88	7.17
Long-Term Debt	-	0.15	0.48
Total Long-Term Liabilities	-	0.15	0.48
Total Liabilities	-	6.03	7.65
Total Debt	1.35	0.96	1.81
Debt Growth	-	-46.87%	-
Retained Earnings	-	-1.08	-1.16
Comprehensive Income	-	0	0
Shareholders' Equity	-0.68	-1.15	-1.27
Net Cash / Debt	1.41	2.03	1.94
Net Cash / Debt Growth	-	4.67%	-
Working Capital	-2.28	-2.21	-3.05

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).